Related Experiment Video
Updated: May 13, 2025

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Diagnosing Alexander disease in adults.
David S Lynch1,2, Charles Wade3, Alise K Carlson4
1Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK david.lynch.13@ucl.ac.uk.
Alexander disease is a rare genetic neurological disorder caused by GFAP gene variants. Adult-onset symptoms are diverse, requiring comprehensive evaluation for timely diagnosis and potential intervention.
Area of Science:
- Neurology
- Genetics
- Neurodegenerative Diseases
Background:
- Alexander disease is a rare, fatal genetic neurological disorder.
- Pathogenic variants in the glial fibrillary acidic protein (GFAP) gene cause Alexander disease.
- Symptoms vary significantly with age of onset, presenting differently in children versus adults.
Purpose of the Study:
- To describe adult-onset Alexander disease cases.
- To guide recognition of distinctive clinical and radiological features in later-onset forms.
- To emphasize the importance of timely diagnosis for potential interventions.
Main Methods:
- Detailed case descriptions of adult-onset Alexander disease patients.
- Review of clinical presentations.
- Analysis of neuroimaging characteristics.
- Genetic testing confirmation.
Main Results:
- Adult-onset Alexander disease presents with heterogeneous and non-specific symptoms.
- Distinctive clinical signs include bulbar signs, ataxia, and autonomic dysfunction.
- Diagnosis requires a combination of clinical evaluation, neuroimaging, and genetic testing.
Conclusions:
- Early recognition of adult-onset Alexander disease is crucial.
- Comprehensive evaluation aids in diagnosing this rare genetic disorder.
- Earlier interventions may mitigate disease severity or slow progression.
More Related Videos
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Lysosomal Hydrolases